Actual Medicinal Product (AMP) Ropinirole 4mg modified-release tablets (Krka UK Ltd)

Stability Information

Stability
We do not have stability information for these medicines and therefore cannot make a recommendation on suitability in an MCA.
Notes
There are no stability notes available for this medicine.
Generic
Ropinirole
Formulation
Ropinirole 4mg modified-release tablets
  • Ropinirole
    • Ropinirole 4mg modified-release tablets

      • Ropinirole 4mg modified-release tablets (Krka UK Ltd)

Alternative Suppliers (17)

ReQuip XL 4mg tablets (GlaxoSmithKline UK Ltd)
ReQuip XL 4mg tablets (Sigma Pharmaceuticals Plc)
ReQuip XL 4mg tablets (Necessity Supplies Ltd)
ReQuip XL 4mg tablets (DE Pharmaceuticals)
Ralnea XL 4mg tablets (Krka UK Ltd)
Repinex XL 4mg tablets (Aspire Pharma Ltd)
Raponer XL 4mg tablets (Accord-UK Ltd)
Ipinnia XL 4mg tablets (Ethypharm UK Ltd)
Ropiqual XL 4mg tablets (Milpharm Ltd)
Ropinirole 4mg modified-release tablets (Krka UK Ltd)
ReQuip XL 4mg tablets (Waymade Healthcare Plc)
ReQuip XL 4mg tablets (Mawdsley-Brooks & Company Ltd)
Spiroco XL 4mg tablets (Teva UK Ltd)
Aimpart XL 4mg tablets (Zentiva Pharma UK Ltd)
Ropinirole 4mg modified-release tablets (Colorama Pharmaceuticals Ltd)
Ropilynz XL 4mg tablets (Lupin Healthcare (UK) Ltd)
Ropinirole 4mg modified-release tablets (Viatris UK Healthcare Ltd)